18
Views
1
CrossRef citations to date
0
Altmetric
Review

Injection therapy for stress urinary incontinence in adult women

&
Pages 205-213 | Published online: 09 Jan 2014

References

  • Elving LB, Foldspang A, Lam GW et al. Descriptive epidemiology of urinary incontinence in 3100 women age 30–59. Scand. UroL NephroL 125 (Suppl.), 37–43 (1989).
  • Urinary incontinence-ACOG Technical Bulletin, No 213, October 1995 (Replaces No. 100, January 1987). Int. J. Obstet. GynecoL 52,75–86 (1996).
  • Wilson PD, Herbison RM, Herbison GP. Obstetric practice and the prevalence of urinary incontinence three months after delivery. Br. j Obstet. GynecoL 103(2), 154–161 (1996).
  • Goldstein M, Hawthorne ME, Engeberg S et al. Urinary incontinence. Why people do not seek help. j Gerontol. Nurs. 18,15–20 (1992).
  • Keane DP, O'Sullivan S. Urinary incontinence: anatomy, physiology and pathophysiology. Baillieres Best Pract. Res. Clin. Obstet. GynaecoL 14,207–226 (2000).
  • Hunskar S, Arnold EP, Burgio K etal. Epidemiology and natural history of urinary incontinence. Int. UrogynecoL 1.11, 301–319 (2000).
  • Abrams P, Cardozo L, Fal M et al The standardization of terminology of lower urinary tract function: report from the Standardization Sub-committee of the International Continence Society. NeurouroL Urodyn. 21,167–178 (2002).
  • Blaivas JG, Olsson CA. Stress incontinence: classification and surgical approach. j Urol. 39,727–731 (1988).
  • Kobashi KC, Leach GE. Stress urinary incontinence. Carr. Opin. UroL 9,285–290 (1999).
  • Leach GE, Dmochowski RR, Appell RA et al. Female Stress Urinary Incontinence Clinical Guidelines Panel summary report on surgical management of female stress urinary incontinence. The American Urological Association. j UroL 158, 875–880 (1997).
  • Bent AE, McLennan MT. Surgical management of urinary incontinence. Obstet. GynecoL Clin. North Am. 25, 883–906 (1998).
  • Benshushan A, Brezezinski A, Shoshani O et al. Periurethral injection for the treatment of urinary incontinence. Obstet. GynecoL Surv. 53(6), 383–388 (1998).
  • Sheriff MKM, Foley S, Mcfarlane J eta]. Endoscopic correction of intractable stress incontinence with silicone micro-implants. Eur. UroL 32,284–288 (1997).
  • Barranger E, Fritel X, Kadoch et al. Results of transurethral injection of silicone microimplants for women with intrinsic sphincter deficiency. j Urol. 164, 1619–1622 (2000).
  • Gtirdal M, Tekin A, Erdoan K et al. Endoscopic silicone injection for female stress urinary incontinence due to intrinsic sphincter deficiency: impact of coexisting urethral mobility on treatment outcome. Urology60, 1016–1019 (2002).
  • Herschorn S, Radomski SB, Steele DJ. Early experience with intraurethral collagen injections for urinary incontinence. j UroL 148,1797–1800 (1992).
  • Monga AK, Robinson D, Stanton SL. Periurethral collagen injections for genuine stress incontinence: a 2-year follow-up. Br. Urol. 76,156–160 (1995).
  • Bent AE, Foote JE, Siegel S et al. Collagen implant in treating stress urinary incontinence in women with urethral hypermobility. Uml. 164(4), 1354–1357 (2001).
  • Herschorn S, Radomski SB. Collagen injections for genuine stress urinary incontinence: patient selection and durability. Int. UrogynecoL 8,18–24 (1997).
  • Steele AC, Kohli N, Karram MM. Periurethral collagen injection for stress incontinence with and without urethral hypermobility. Obstet. Gynecol. 95, 327–331 (2000).
  • Herschorn S, Steele DJ, Radomski S. Follow-up of intraurethral collagen for female stress urinary incontinence. j UroL 156,1305–1309 (1996).
  • Harriss DR, Iacovou JVV, Lemberger RJ. Periurethral silicone microimplants (Macroplastique) for the treatment of genuine stress incontinence. Br. J UroL 78, 722–728 (1996).
  • Usman F, Henalla S. A single transurethral macroplastique injection as primary treatment for stress incontinence in women. J Obstet. GynecoL 18,56–60 (1998).
  • Hidar S, Attyaoui F, De Leval J. Injection périurétrale de microparticules de silicone dans le traitement de l' incontinence urinaire par insuffisance sphinctérienne. Prog. UroL 10,219–223 (2000).
  • Radley SC, Chapple CR, Mitsogiannis IC etal. Transurethral implantation of macroplastique for the treatment of female stress urinary incontinence secondary to urethral sphincter deficiency. Eur. Urol. 39, 383–389 (2001).
  • Buckley J, Lingham K, Scott R. Early experience with a new injectable material for female stress incontinence. Abstract from the Institute of Urology and Nephrology University College London, June, UK (1995) and the British Association of Urological Surgeons (BAUS) Annual Meeting, June, Brighton, UK (1995).
  • Herschorn S. Current status of injectable agents for female stress urinary incontinence. Can.j UroL 8,1281–1289 (2001).
  • Radley SC, Chapple CR, Lee JA. Transurethral implantation of silicone polymer for stress incontinence: evaluation of a porcine model and mechanism of action in vivo. BJU Int. 85,646–650 (2000).
  • Kieswater H, Fischer M, Wober L et al. Endoscopic implantation of collagen (GAX) for the treatment of urinary incontinence. Br. J UroL 69,22–25 (1992).
  • O'Connell HE, McGuire EJ, Aboseif S et al. Transurethral collagen therapy in women.j UroL 154,1463–1465 (1995).
  • Khullar V, Cardozo LD, Abbott D et al. GAX collagen in the treatment of urinary incontinence in elderly women: a two year follow-up. Br. J Obst. Gynaecol. 104, 96–99 (1997).
  • Monga AK, Stanton SL. Urodynamics: prediction, outcome and analysis of mechanism for cure of stress incontinence by periurethral collagen. Br. J. Obstet. GynaecoL 104,158–162 (1997).
  • Dmochowski RR, Appell RA. Injectable agents in the treatment of stress urinary incontinence in women: where are we now? Urology56,32-40 (2000).
  • Murless BC. The injection treatment of stress incontinence. j Obstet. GynaecoL Br. Ernp. 45,67–71 (1938).
  • Quackels R. Deux incontinences aprés adenomectomie gueries par injection de parrafine dans le perinee. Acta UroL Belg. 23,259–262 (1955).
  • Sachse S. Treatment of urinary incontinence with sclerosing agent solutions: indication, results, complications. UroL Int. 15,225–244 (1963).
  • Berg S. Polytef augmentation urethroplasty correction of surgically incurable incontinence by injection technique. Arch. Surg. 107,379–381 (1973).
  • Politano AV. Periurethral polytetrafluoroethylene injection for urinary incontinence. J Urn]. 127, 439–442 (1982).
  • Mittleman RE, Marracchini JV. Pulmonary Teflon granuloma following periurethral Teflon injection for urinary incontinence. Arch. PathoL Lab. Med. 107,611–618 (1983).
  • Boykin W, Rodriquez FR, Brizzolara J et al Complete urinary obstruction following periurethral polytetrafluoroethylene injection for urinary incontinence. ' Urol. 1199–1200 (1989).
  • Malizia AA, Reiman HM, Myers RP et al Migration and granulomatous reaction after periurethral injection of polytef (Teflon). JAMA 251,3277–3281 (1984).
  • Aaronson IA, Rames RA, Green WB eta]. Endoscopic treatment of reflux: migration of teflon to the lungs and brain. Eur. Urol. 23,394–399 (1993).
  • Kiilholma PJ, Chancellor MB, Makinen J etal. Complications of Teflon injection for stress urinary incontinence. NeurouroL Urodyn. 12,131–137 (1993).
  • Hakky M, Kolbusz R, Reyes CV. Chondrosarcoma of the larynx. Ear Nose Throatj 68,60–62 (1989).
  • Lewy RB. Experience with vocal cord injection. Ann. OtoL 85,440–450 (1976).
  • Lee PE, Kung RC, Drutz HP. Periurethral autologous fat injection as treatment for female urinary stress incontinence: a randomized double-blind controlled trial. UroL 165,153–158 (2001).
  • Currie L, Drutz HP, Oxorn D. Adipose tissue and lipid drop embolism following periurethral injection of autologous fat: case report and review of the literature. Int. Urogynecol. J Pelvic Floor Dysfunct. 8, 923–926 (1997).
  • Palma PC, Riccetto CL, Netto Jr NR. Urethral pseudolipoma: a complication of periurethral lipo-injection for stress urinary incontinence in a women. J UroL 155(2), 646 (1996).
  • Su TH, Hsu CY, Chen JC. Injection therapy for stress incontinence in women. Urogynecol. 10,200–206 (1999).
  • Lightner DJ. Review of the available urethral bulking agents. Carr. Opin. Urol. 12,333–338 (2002).
  • Cross CA, English SF, Cespedes RD et al A follow-up on transurethral collagen injection therapy for urinary incontinence. UroL 159,106–108 (1998).
  • Corcos J, Fournier C. Periurethral collagen injection for the treatment of female stress urinary incontinence: 4-year follow-up results. Urology54, 815–818 (1999).
  • Canning DA, Peters CA, Gearhart JP et al. Local tissue reaction to glutaraldehyde crosslinked bovine collagen in the rabbit bladder. ' Urol. 139(Suppl.), 381 (1998).
  • Stothers L, Goldenberg SL, Leone EF Complications of periurethral collagen injection for stress urinary incontinence. J UroL 159,806–807 (1998).
  • Berman CJ, Kreder KJ. Comparative cost analysis of collagen injection and fascia lata sling cystourethropexy for the treatment of Type 3 incontinence in women. J UroL 157,122–124 (1997).
  • Schulman CC. Biocompatibility of injected materials in urology. In: Implanted and Injected Materials in Urology Buzelin JM (Ed.). ISIS Medical Media, Oxford, UK, Chapters 1 and 2 (1995).
  • Solomon LZ, Birch BR, Cooper AJ eta]. Nonhomologous bioinjectable materials in urology: size matters? BJU Int. 85,641–645 (2000).
  • Tinkler JB, Campbell HJ, Senior JM et al. Evidence for an association between the implantation of silicones and connective tissue disease. Medical Device Directorate (UK Department of Health) Report MDD/92/42, 1–65 (1993).
  • ter Meulen PhH, Berghmans LCM, van Kerrebroeck PhEVA. Systematic review: efficacy of silicone microimplants (Macroplastique n therapy for stress urinary incontinence in adult women. Eur. Urol. 44,573–582 (2003).
  • Koelbl H, Saz V, Doerfler D et al. Transurethral injection of silicone microimplants for intrinsic urethral sphincter deficiency. Obstet. Gynecol. 92, 332–336 (1998).
  • Lightner D, Calvosa C, Andersen R et al. A new injectable bulking agent for treatment of stress urinary incontinence: results of a multicenter, randomized, controlled, double-blind study of Durasphere. Urology 58,12–15 (2001).
  • Pannek J, Brands FH, Senge T. Particle migration after transurethral injection carbon-coated beads for stress urinary incontinence. J Urol. 166,1350–1353 (2001).
  • Mayer R, Lightfoot M, Jung I. Preliminary evaluation of calcium hydroxylapatite as a transurethral bulking agent for stress urinary incontinence. Urology57, 434–438 (2001).
  • Stenberg A, Larsson E, Lindholm A et al. Injectable dextranomer-based implant: histopathology, volume changes and DNA-analysis. Scand. J Urol. NephroL 33, 355–361 (1999).
  • Stenberg A, Larsson G, Johnson P et al. DiHA Dextran copolymer, a new biocompatible material for endoscopic treatment of stress incontinent women. Short-term results. Acta Obstet. Gynecol. Scand. 78,436–442 (1999).
  • Stenberg AM, Sundin A, Larsson BS etal. Lack of distant migration after injection of a 125iodine-labeled dextranomer-based implant into the rabbit bladder. J Urol. 158,1937–1941 (1997).
  • Lackgren G, Wahlin N, Skoldenberg E et al. Long-term follow-up of children treated with dextranomer/hyaluronic acid copolymer for vesicoureteral reflux. J Urol. 166,1887–1892 (2001).
  • Lackgren G, Wahlin N, Stenberg A. Endoscopic treatment of children with vesico-ureteric reflux. Acta Paediatr. 88(Suppl.), 62–71 (1999).
  • Dmochowski RR, Appell RA. Delivery of injectable agents for treatment of stress urinary incontinence in women: evolving techniques. Tech. Urol. 7,110–117 (2001).
  • Gottfried HW, Maier S, Gschwend J et al. Minimally invasive treatment of stress urinary incontinence by collagen administration. Comparison between endosonography controlled and transurethral submucous collagen injection. Urologe A35, 6–10 (1996).
  • Henalla SM, Hall V, Duckett JRA et al A multicenter evaluation of a new surgical technique for urethral bulking in the treatment of genuine stress incontinence. Br. Obstet. Gynecol. 107,1035–1039 (2000).
  • Tamanini JTN, D'Ancona CAL, Tadini V et al. Macroplastique implantation system for the treatment of female stress urinary incontinence. j Urol. 169,2229–2233 (2003).
  • Van Kerrebroeck P, ter Meulen F, Larson G et al. Efficacy and safety of a novel sytem (NASHA/Dx copolymer via the Implacer device) for the treatment of SUI. Urology 64,276–281 (2004).
  • Shah J. Injectables and stress urinary incontinence. Urol. News 2,7–11 (1997).
  • Pickard R, Reaper J, Wyness L et al. Periurethral injection therapy for urinary incontinence in women. The Cochrane Database of Systematic Reviews, Oxford, UK, 1 (2003).
  • Robinson D, Anders K, Cardozo L et al. What do women want? Interpretation of the concept of cure. J Pelvic Surg. Med. 9, 273–277 (2003).
  • Strasser H, Tiefenthaler M, Steinlechner M et al. Age-dependent apoptosis and loss of rhabdosphincter cells. J Urol. 164, 1781–1785 (2000).
  • Bedir S, Kilciler M, Ozgok Y et al. Long-term complication due to dextranomer based implant: granuloma causing urinary obstruction. J Urol. 172, 247–248 (2004).
  • Dmochowski RR, Appell RA. Advancements in minimally invasive treatments for female stress urinary incontinence: radiofrequency and bulking agents. Carr. Urol. Rep. 4,35–35 (2003).
  • Bent AE, Tutrone RT, McLennan MT et al.Treatment of intrinsic sphincter deficiency using autologous ear chondrocytes as a bulking agent. Neurol. Urodyn. 20, 157–165 (2001).
  • Yiou R, Yoo JJ, Atala A. Restoration of functional motor units in a rat model of sphincter injury by muscle precursor cell autografts. Transplantation 76,1053–1060 (2003).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.